
PULLBACK IN MEDICAL DEVICE COMPANY BOSTON SCIENTIFIC (BSX) IS AN OPPORTUNITY FOR LONG TERM INVESTORS
By Nigam Arora Pullback Is Opportunity Boston Scientific (BSX) has built one of the strongest franchises in the global medical device industry. Through disciplined innovation and targeted strategic expansion, the company has consistently strengthened its position in fast growing therapeutic categories. The pullback in BSX is a buying opportunity for the long term investor. Reason For Pullback The pullback in BSX is the direct result of the company’s acquisition of Penumbra (PEN). Markets frequently react negatively when a major acquisition is announced or completed. The reason is simple: acquisitions are dilutive in the short term. When a large company buys another company:






